Table 2.
Association between sagittal abdominal diameter and serum klotho concentration.
| Models 1 | β 2 (95% CI) | p Value |
|---|---|---|
| Model 1 | −3.530 (−6.652, −0.408) | 0.027 |
| Model 2 | −12.133 (−19.419, −4.846) | 0.001 |
| Model 3 | −13.332 (−20.790, −5.875) | <0.001 |
| Model 4 | −12.023 (−19.517, −4.530) | 0.002 |
1 Adjusted covariates: Model 1 = unadjusted; Model 2 = age, race, gender, BMI; Model 3 = Model 2 + systolic blood pressure, AST, TG, fasting glucose; Model 4 = Model 3 + history of CHF, CHD, angina/angina pectoris, and history of smoking. 2 β coefficients were interpreted as change in serum Klotho concentration for each increase in sagittal abdominal diameter. Abbreviation: AST, aspartate aminotransferase; BMI, body mass index; CHD, coronary heart disease; CHF, congestive heart failure; TG: triglyceride.